BIO.News Newsletter

We take a few days off—and there’s a new coronavirus variant. We tell you why you don’t need to panic and what the vaccine manufacturers are doing to address it, plus why synthetic DNA is driving the next phase of the genomics revolution. (730 words, 3 minutes, 39 seconds)

Ahead of Thanksgiving, we look at how gene editing is improving our feast tomorrow and all year—plus, giving thanks (and resources) for America’s family caregivers. (696 words, 3 minutes, 28 seconds)  Happy Thanksgiving! Good Day BIO will take a quick break for the holiday. We will resume publication on Monday, November 29. Have a great weekend!

As World Antimicrobial Awareness Week is coming to a close, the season finale of the I am BIO Podcast looks at the challenge of antimicrobial resistance and potential solutions. We’ve also got the tea on how gene editing is improving your favorite hot beverages. (665 words, 3 minutes, 19 seconds)

BREAKING NEWS: House passes drug price controls

We begin a short week with a roundup of health policy news plus what 76 Members of Congress (and BIO) said about Mexico’s treatment of agricultural biotechnology. (701 words, 3 minutes, 30 seconds)

BIO recently went to Geneva to discuss vaccine equity—we have a readout and what to expect from the upcoming WTO ministerial. Plus, everyone’s talking about carbon, so we examine the latest technologies to capture, store, and recycle it. (819 words, 4 minutes, 5 seconds)

World Antimicrobial Awareness Week begins today, so we explore the problem and possible solutions. We also recap a congressional forum yesterday on pharmacy benefit managers (PBMs) and why they must be part of drug pricing discussions. (960 words, 4 minutes, 48 seconds)

The flurry of pre-Thanksgiving recess activity on Capitol Hill continues, as a House Agriculture subcommittee looks at agricultural trade policy and we gear up for a vote on the Build Back Better Act (including drug price controls). (868 words, 4 minutes, 20 seconds)

BIO launched a new website to help patients and their families understand and enroll in clinical trials—we have details. Plus, BIO weighed in on today’s House Agriculture Committee hearing on America’s renewable economy, and we may soon have an Under Secretary of Agriculture. (732 words, 3 minutes, 39 seconds)

Congress is back—and drug pricing could be on the agenda. But here’s how we can modernize Medicare Part D without harming future cures. We also take a quick look at what happened during COP26 and President Biden’s pick for FDA Commissioner. (1,000 words, 5 minutes)